Anti-CD72 [BU40]
Ab00831-10.0
ApplicationsFlow Cytometry, Other Application
Product group Antibodies
TargetCD72
Overview
- SupplierAbsolute Antibody
 - Product NameAnti-CD72 [BU40]
 - Delivery Days Customer7
 - Application Supplier NoteThis antibody has been used to investigate cell-surface expression of CD72 in FACS analysis (Kataoka et al, 2013). This antibody has been shown to induce resting B cells to enter the G1 phase of the cell cycle, stimulate B cell expression of major histocompatibility complex class II antigen and potentiate the capacity of IL-4 to induce CD23 production (Katira et al, 1992). It also stimulates TNF-alpha and IL-6 production in CD14+ monocytes (Yoshida et al, 2015). Ligation of CD72 by this antibody has been observed to suppress the proliferation of an acute myelogenous leukaemia cell line (Kataoka et al, 2013).
 - ApplicationsFlow Cytometry, Other Application
 - Applications SupplierFC; stimulatory; activate
 - CertificationResearch Use Only
 - ClonalityMonoclonal
 - Clone IDBU40
 - Gene ID971
 - Target nameCD72
 - Target descriptionCD72 molecule
 - Target synonymsCD72b, LYB2, B-cell differentiation antigen CD72, CD72 antigen, lyb-2
 - HostHuman
 - IsotypeIgG1
 - Protein IDP21854
 - Protein NameB-cell differentiation antigen CD72
 - Scientific DescriptionThis chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.
 - Reactivity SupplierHuman
 - Reactivity Supplier NoteThis antibody was raised against the HF B1 plasmacytoid cell line, which is considered to be late B-like.
 - Storage Instruction-20°C,2°C to 8°C
 - UNSPSC12352203
 

![IHC-P analysis of human tonsil tissue using GTX41843 CD72 antibody [Bu40].](https://www.genetex.com/upload/website/prouct_img/normal/GTX41843/GTX41843_2757_IHC-P_w_23051500_798.webp)





